Resonance Specialties Approves Q1 FY27 Results, Acquires Mfg Unit

Resonance Specialties Ltd announced the outcome of its Board Meeting held on August 4, 2026. The board approved the unaudited financial results for the first quarter ended June 30, 2026, along with the limited review report. Additionally, the company approved the purchase of a manufacturing facility, including land, buildings, plant, and machinery, located in Mandideep, Madhya Pradesh, from Kaygee Laboratories Private Limited, a related party. The acquisition is on a slump sale basis for a consideration of ₹29.98 crores and is subject to shareholder approval. The manufacturing unit was originally set up by a former promoter group company and has been supplying chemical intermediates and APIs to Resonance Specialties on a job work basis. The acquisition aims to secure uninterrupted production, enhance operational control, and reduce outsourcing costs.